関連する実験動画

Updated: Jul 18, 2026

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development

Published on: February 11, 2019

開発途上国の12カ国で合理的な薬物使用に関するフィールドテストが行われました

H V Hogerzeil¹, Bimo, D Ross-Degnan

¹World Health Organization, Action Programme on Essential Drugs, Geneva, Switzerland.

Lancet (London, England)

|December 4, 1993

まとめ

この研究は,開発途上国の薬物使用指標を導入し,より良い処方と薬物使用を支援しています. これらの指標は,意識を高め,ポリファーマシーなどの問題を特定し,介入の有効性を測定するのに役立ちます.

科学分野:

グローバル・ヘルスグローバル・ヘルス
薬学経済学薬学経済学
医療サービス研究医療サービス

背景:

開発途上国における薬物使用と処方量の改善は,世界保健の優先事項である.
客観的な評価ツールは,薬物使用慣行の評価と改善に不可欠です.

研究の目的:

開発途上国12カ国で開発され,検証された薬物使用指標のセットを提示する.
これらの指標の実践的な応用を様々な医療環境で実証する.

主な方法:

標準化された薬物使用指標のセットの開発とテスト.
12の開発途上国における指標の適用による評価と介入の評価.

主要な成果:

マラウィとバングラデシュでは,処方医の意識を高めるために,指標が使用されました.
特定された優先事項には,ポリファーマシー (インドネシア,ナイジェリア),注射剤の過剰使用 (ウガンダ,スーダン,ナイジェリア),投与スケジュールに対する患者の理解の欠如 (マラウイ) が含まれる.
イエメン,ウガンダ,スーダン,ジンバブエでの量化介入の影響.

結論:

開発された薬物使用指標は,開発途上国の処方行動と薬物使用を改善するための貴重なツールです.
これらの指標は,対象を絞った介入と医療の質のモニタリングを容易にする.

キーワード:

抗生物質抗生物質とはデータ収集データの収集保健医療の提供について発展途上国開発途上国流通活動流通活動ドラッグドラッグドラッグ健康健康健康健康とは保健施設保健施設口腔リヒダレーションによる口腔リヒダレーション組織と管理組織と管理処方箋 - 標準 - 処方箋 - 標準は,処方箋 - 標準は,処方箋 - 標準は,処方箋 - 標準は,処方箋 - 標準は,処方箋 - 標準は,処方箋 - 標準は,処方箋 - 標準は,処方箋 - 標準は,処方箋 - 標準は,処方箋 - 標準は,処方箋 - 標準は,処方箋 - 標準は,処方箋 - 標準は,処方箋 - 標準は,処方箋 - 標準は,処方箋 - 標準は,処方箋 - 標準は,処方箋 - 標準は,処方箋 - 標準は,処方箋 - 標準は,処方箋 -プログラム活動プログラム活動プログラムプログラムプログラム研究方法論研究方法論田舎の保健センタートリートメント治療法

さらに関連する動画

Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones

Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones

Published on: February 5, 2018

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

関連する概念動画

Clinical Trials: Overview

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...

Drug Regulation

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...

Preclinical Development: Overview

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...

Drug Concentrations: Measurements

Drug Concentrations: Measurements

Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma —...

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...